Latest News and Press Releases

ROCKVILLE, Md., May 3, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its first quarter 2012 financial results on Thursday, May 10, 2012, after the...

ROCKVILLE, Md., April 23, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced plans to merge with Biota Holdings Limited (ASX:BTA), a Melbourne, Australia company. The...

ROCKVILLE, Md., March 14, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced fourth quarter and year-end financial results for the three and twelve month periods ended...

ROCKVILLE, Md., March 7, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its 2011 fourth quarter and full-year financial results on Wednesday, March...

Smoking Cessation Immunotherapy Failed to Meet Primary Endpoint Board of Directors retains Piper Jaffray to assist with Strategic alternatives ROCKVILLE, Md., Nov. 7, 2011 (GLOBE NEWSWIRE)...

ROCKVILLE, Md., Nov. 2, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its third quarter financial results for the quarter ended September 24, 2011. The Company's net...

ROCKVILLE, Md., Oct. 26, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) will report its third quarter 2011 financial results on Wednesday, November 2, 2011, after the market close. The...

ROCKVILLE, Md., Aug. 25, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that its Board of Directors adopted a stockholder Rights Agreement designed to preserve its...

ROCKVILLE, Md., Aug. 16, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) has received a $5 million payment from Fresenius USA Manufacturing, Inc. (Fresenius) that was triggered by the...

ROCKVILLE, Md., Aug. 3, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its second quarter financial results for the three month period ended June 25, 2011. The Company...